Catalyst Wire Dossier Catalyst Wire Dossier

Ebanga

ansuvimab-zykl · Ridgeback Biotherapeutics, LP
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Ebanga, covering 2020-12-21 to 2026-02-18. Get the full timeline:

Most recent: FDA Approved: EBANGA — Supplemental Application (Emergent Manufacturing Operations Baltimore, LLC)

See pricing